Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 07, 2018 16:05 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports Third Quarter 2018 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
October 31, 2018 08:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
October 05, 2018 07:01 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Highlights Breadth of Innovative Pipeline at R&D Day

-Updated response rate of 50% in advanced renal carcinoma treated with CB-839 + cabozantinib-CB-839 clinical trial collaboration with Pfizer -Presentation of INCB001158 data expected in 1H2019-R&D...
October 05, 2018 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE® (palbociclib) and talazoparib in Combination with CB-839

SOUTH SAN FRANCISCO, Calif., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer...
September 26, 2018 08:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Host R&D Day and Webcast on October 5, 2018

SOUTH SAN FRANCISCO, Calif., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
September 24, 2018 08:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference and the Leerink Partners Rare Disease & Oncology Roundtable

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
August 29, 2018 07:05 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Participate in the Citi 13th Annual Biotech Conference and the Wells Fargo Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer...
August 07, 2018 16:08 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences Reports Second Quarter 2018 Financial Results and Recent Highlights

-Two Novel Programs Entering Clinical Development -Calithera to Host Conference Call Today at 2:00 p.m. Pacific Time/ 5:00 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., Aug. 07, 2018 (GLOBE...
August 01, 2018 07:00 ET | Source: Calithera Biosciences, Inc.

Calithera Biosciences to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

SOUTH SAN FRANCISCO, Calif., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small...
June 06, 2018 05:01 ET | Source: Calithera Biosciences, Inc.

Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June

SOUTH SAN FRANCISCO, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer...